Sign in to view content

Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

David M. Brown, MD

Video
Published 2021

Related

Photobiomodulation for DME With Good VA: DRCRnet Protocol AE
Judy E. Kim, MD, FASRS
Updates from the Field
2021
Obstructive Sleep Apnea as a Risk Factor for Diabetic Retinopathy Progression and Systemic Complications
Ehsan Rahimy, MD
Annual Meeting Talks
2024
Imaging Signatures and Cytokine Expression in Diabetic Macular Edema From the IMAGINE Study: Biomarker Exploration for Precision Medicine
Sruthi Arepalli, MD
On Demand Cases, Courses, and Papers
2020

Category: Pharmacology

See more